高龄冠心病患者介入治疗的安全性及有效性评价

Evaluation of safety and efficacy of interventional therapy for elderly patients with coronary heart disease

目的:评价高龄冠心病(年龄≥75岁)患者接受介入治疗的有效性及安全性。方法:收治接受冠脉介入治疗的冠心病患者208例。按年龄分高龄组(年龄≥75岁)52例和非高龄组(年龄<75岁)156例。比较两组冠脉病变情况、即刻手术成功率、完全血运重建率、手术相关并发症、院内死亡率。结果:高龄组女性比例,合并高血压、糖尿病、肾功不全比例,ACS发生率均高于非高龄组,差异具有统计学意义(P<0.05)。高龄组多支病变比例、C型病变比例高于非高龄组,差异具有统计学意义(P<0.05)。高龄组完全血运重建率明显低于非高龄组,差异具有统计学意义(P<0.05)。结论:高龄冠心病患者进行PCI治疗是安全、有效的,但其完全血运重建比例明显减少。

Objective:To evaluate the safety and efficacy of interventional therapy for elderly patients(age≥75years old)with coronaryheart disease.Methods:208patients with coronary heart disease treated by interventional therapy were selected.According tothe age group,they were divided into the elderly group(age≥75years)in52cases and the non-elderly group(age<75years)in156cases.The coronary lesion,immediate operative success,complete revascularization rate,operative complications and in-hospitalmortality were compared between groups.Results:The ratio of female,combined with hypertension,diabetes,renal insufficiency andACS in the elderly group were higher than those in the non elderly group,and the difference was statistically significant(P<0.05).The proportion of multivessel disease and type C lesion in the elderly group was higher than that in the non elderly group,and thedifference was statistically significant(P<0.05).The rate of complete revascularization in the elderly group was significantly lowerthan that in the non elderly group,and the difference was statistically significant(P<0.05).Conclusion:It is safe and effective forPCI treatment in elderly patients with coronary heart disease.But the proportion of complete revascularization is significantly reduced.